To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
BASF declares end of Force Majeure on Plastomoll DNA, Palatinol N, Hexamoll DINCH and selected Palamoll grades
13-08-2010: BASF SE has fixed the causes for the Force Majeure for its iso-Nonanol- (INA) based plasticizers produced in Ludwigshafen, Germany, and can hence declare the termination of Force Majeure.
The Force Majeure was originally announced on July 21, 2010, due to a shortage of raw materials to produce the plasticizers Plastomoll® DNA, Palatinol® N, Hexamoll® DINCH and selected Palamoll® grades (652, 654, 656, 858) caused by an unforeseeable technical defect in the INA plant in Ludwigshafen, Germany.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
- 1Drew Industrial Division of Ashland Specialty Chemical Company purchases industrial water-treatment business of London-based Fer
- 2Allegra® Launched in Japan
- 3LG-DOW Polycarbonate Plant Starts Production in Korea to Effectively Meet Regional Needs
- 4Honeywell Appoints Terrence Hahn as Vice President and General Manager for Fluorine Products
- 5Putting electronic cigarettes to the test
- 6Caflon® surfactants from Univar as substitutes for banned nonylphenol ethoxylates
- 7Not just cars, but living organisms need antifreeze to survive
- 8Plurafac LF 303 - Plurafac LF 305: The new generation of low-foam surfactants
- 9Knoll AG: Pharma business sold for $6.9 billion:
- 10Fluor Corporation's Henry Kister Honored by Chemical Engineering Magazine
- BASF strengthens its enzyme technology footprint
- Membrane elements from LANXESS approved for drinking water applications
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- ZEISS presents half-year financial figures
- Merck wants to achieve 2014 goals already this year following a successful start
